Thrivent Financial For Lutherans Theratechnologies Inc. Transaction History

Thrivent Financial For Lutherans

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.37 - $3.24 $73,209 - $100,083	-30,890 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$2.92 - $3.76 $90,198 - $116,146	30,890 New	30,890 $120,000
Q3 2020 Nov 10, 2020	SELL	$1.96 - $2.92 $60,544 - $90,198	-30,890 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.43 - $3.23 $5,488 - $12,396	-3,838 Reduced 11.05%	30,890 $49,000
Q4 2019 Feb 13, 2020	BUY	$2.74 - $4.2 $95,154 - $145,857	34,728 New	34,728 $115,000
Q4 2017 Feb 14, 2018	SELL	$5.05 - $6.43 $537,825 - $684,795	-106,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.64 - $6.24 $600,660 - $664,560	106,500	106,500 $640,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.